Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Naratriptan, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Naratriptan impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Naratriptan-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Naratriptan-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Naratriptan Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Naratriptan-d3 | Stable Isotopes | CS-O-02769 | 1190043-69-6 | In Stock |
| N-Benzyloxy Naratriptan-d3 | Stable Isotopes | CS-T-102889 | 1794937-02-2 | Enquire |
| Naratriptan-d3 Hydrochloride | Stable Isotopes | CS-T-94960 | 1190021-64-7 | Enquire |
API
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Naratriptan | API | CS-O-01949 | 121679-13-8 | In Stock |
| Naratriptan (HBr salt) | API | CS-EO-03719 | 1189349-28-7 | Enquire |
| Naratriptan (Sulfate salt) | API | CS-EO-03718 | 1189349-38-9 | Enquire |
| Naratriptan Hydrochloride | API | CS-O-00210 | 143388-64-1 | In Stock |
Impurity
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Naratriptan 2-Carboxylic Acid | Impurity | CS-T-104143 | 874583-40-1 | Enquire |
| Naratriptan Impurity 4 chloride | Impurity | CS-O-57571 | ---- | Enquire |
| Naratriptan Impurity 4 Iodide | Impurity | CS-O-53578 | ---- | Enquire |
| Naratriptan Impurity F Iodide | Impurity | CS-EO-03717 | 2144776-32-7 (Freebase) | Enquire |
| Naratriptan N-Oxide | Impurity | CS-T-59153 | 1159977-52-2 | Enquire |
| N-Sulfamoylethyl naratriptan pyridinium(free salt form) | Impurity | CS-O-44112 | 2144776-32-7 | Enquire |
| 3,4-Dihydro Naratriptan | Impurity | CS-T-18864 | 121679-20-7 | Enquire |
| N-(2-Methylsulfamoylethyl) Naratriptan Hydrochloride | Impurity | CS-T-34872 | 1346600-26-7 | Enquire |
| Naratriptan Impurity F | Impurity | CS-P-01821 | 2144776-33-8 | Enquire |
Nitrosamine
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| N,N-dinitroso Naratriptan dimer impurity | Nitrosamine | CS-O-54280 | ---- | Discontinued |
| N-Nitroso Desmethyl Naratriptan | Nitrosamine | CS-O-58603 | ---- | Enquire |
| N-Nitroso Naratriptan | Nitrosamine | CS-T-56667 | 1216880-64-6 | Discontinued |
| N-Nitroso Naratriptan | Nitrosamine | CS-EO-01226 | 1216880-64-6 | Discontinued |
| N-Nitroso Naratriptan dimer impurity | Nitrosamine | CS-O-51753 | Not Available | Enquire |
| N-Nitroso Naratriptan N-alkyl pyridinium impurity | Nitrosamine | CS-O-51756 | Not Available | Discontinued |
| N-Nitroso Naratriptan pyridinium impurity | Nitrosamine | CS-O-51754 | Not Available | Discontinued |
| N-Nitroso N-desmethyl dehydroNaratriptan | Nitrosamine | CS-O-51752 | ---- | Enquire |
| N-Nitroso Naratriptan N-alkyl impurity | Nitrosamine | CS-O-51755 | Not Available | Discontinued |
Therapeutic
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Bisaryl Naratriptan | Therapeutic | CS-P-01818 | 1346604-16-7 | Enquire |
| Naratriptan Pyridinium Iodide | Therapeutic | CS-P-01819 | ---- | Enquire |
| N-Sulfamoylethyl Naratriptan | Therapeutic | CS-P-01820 | 1346746-73-3 | Enquire |